What we do
Ipsen is a leading biopharmaceutical group dedicated to prolonging and improving lives and health outcomes through innovative medicines in oncology, neuroscience and rare disease.
Our therapeutic areas
Patients and society are at the core of our mission. We achieve our goal of improving lives and health outcomes through close collaboration with patient organizations, patients, caregivers, nurses, physicians and communities on a local and global level.
Oncology
Ipsen has a specialist portfolio in niche oncology. We have been active in this area since 1986, branching out from a strong foundation in neuroendocrine tumors (NETs), kidney, liver, pancreatic, prostate, bladder, and breast cancers.
Neuroscience
Ipsen continues its long-standing commitment to a multi-modal approach to treating mobility impairment in adult and pediatric patients and improving their quality of life.
Rare disease
Ipsen takes a patient-focused approach to improving the lives of people affected by rare disorders and develops high-quality, innovative treatments that address unmet needs.
Consumer HealthCare
Ipsen’s long-standing expertise spans the value chain, with special expertise in gastrointestinal (GI) disorders, neurodegenerative pathologies and rheumatology, as well as a constantly expanding portfolio.
2019 Annual Report
With our most robust R&D pipeline yet, continued financial growth and the execution of our first materiality matrix assessment for CSR, 2019 was a record year for Ipsen.
Explore Our 2019 Digital Annual ReportCareers at Ipsen
Ipsen offers exciting opportunities that will challenge your abilities , expand your skills and reward your contribution in a positive atmosphere of personal and professional development.
Search Ipsen positionsResearch & Development
Commitment
Research and development is a key element of our strategy, reflecting our commitment to improving patients’ lives and health outcomes. We will secure our future by building a sustainable pipeline of innovative medicines in our three therapeutic areas.
Read more
Research & Development
Partnerships
By partnering with Ipsen, you will gain access to the powerhouse development and commercialization teams of a global biopharmaceutical company that shares your values and vision.
Investors
As a global pharmaceutical company with a biotech mindset and a proven ability to provide new, life-changing therapies, Ipsen is a leading player in its three core therapeutic areas.
News Center
News Center